Driving Access to Health |Ex Head-AI platforms |Serial Innovator| Independent Director|Purpose Alchemist
The Gene light switch Today's gene therapy faces a critical challenge: traditional methods introduce foreign proteins to regulate genes, often provoking detrimental immune responses as the body combats these alien elements. Addressing this, Baylor College of Medicine researchers, led by Dr. Laising Yen, have developed an innovative RNA-based technology. Their method employs small, FDA-approved molecules to interact with RNA, avoiding immune activation. This 'light switch' for genes, adjustable with common drugs like tetracycline, promises precise control within safe drug concentrations. This breakthrough, a decade in the making and published in Nature Biotechnology, has potential applications in various conditions, including genetic disorders and cancer, offering a more targeted and safer approach to gene therapy. Amit Saxena Ajay Nandgaonkar Sanju Senthil Kumar Suchitaa Paatil Dr Taruna Anand #accessAIchemy #access #genetherapy read more :https://lnkd.in/ggbJ_DAm